For IM or IV administration please consult your physician
MICC injections can be especially beneficial for individuals looking to increase energy, support weight management, or enhance overall metabolic health
From 1990 to 2019, China experienced a 30% reduction in age standardized incidence rate (ASIR), with an annual decrease of 1.2% (3)
Because weight loss with GLP-1 medications is dose-dependent, using a weakened version of the drug can stall the metabolic progress you have worked so hard to achieve
Retatrutide, a drug in clinical trials, is touted for its potential to reduce visceral fat in individuals with obesity
Not every patient will be prescribed a brand-name option, your clinician will determine whats appropriate for your situation